Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

272.03 -4.36 (-1.58%)
Streaming Delayed Price Updated: 12:18 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 662,435
Open 276.07
Bid (Size) 271.89 (1)
Ask (Size) 272.10 (1)
Prev. Close 276.39
Today's Range 271.61 - 277.24
52wk Range 253.30 - 339.17
Shares Outstanding 537,700,000
Dividend Yield 3.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Weight of Progress: A New Era Dawns for Anti-Obesity Drugs, Reshaping Markets and Health
The global anti-obesity drug market is experiencing an unprecedented surge, driven by groundbreaking advancements in pharmacotherapy, particularly the advent of highly effective GLP-1 receptor... 
Via MarketMinute
2 Healthcare Dividend Stocks to Buy and Hold
These drugmakers have competitive yields and have increased their dividends at a good clip. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+4.9%
+4.9%
1 Month
-8.2%
-8.2%
3 Month
-8.0%
-8.0%
6 Month
-14.2%
-14.2%
1 Year
-18.9%
-18.9%

More News

Read More
The Dawn of a New Era: How GLP-1s, AI, and Robotic Surgery Are Reshaping Healthcare and Investment
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
Zai Lab To Await More Trial Data Before Filing For Regulatory Approval For Experimental Cancer Drug
Via Stocktwits
1 Cash-Producing Stock to Target This Week and 2 Facing Challenges
Via StockStory
Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis
Via Benzinga
Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
From Kyowa Kirin
Via GlobeNewswire
If You'd Invested $10,000 in Amgen Stock (AMGN) 3 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Topics Economy
Nvidia Just Went Quantum—And ETFs Are Scrambling To Catch Up
Via Benzinga
Topics ETFs
Why Is Sanofi Stock Falling Thursday?
Via Benzinga
Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug
Via Benzinga
2 Safe-and-Steady Stocks to Keep an Eye On and 1 Facing Challenges
Via StockStory
2 Profitable Stocks Worth Your Attention and 1 We Avoid
Via StockStory
2 Dividend Stocks to Hold for the Next 10 Years
Via The Motley Fool
Topics Economy
2 Large-Cap Stocks to Target This Week and 1 That Underwhelm
Via StockStory
Deep Dive Into Amgen Stock: Analyst Perspectives (9 Ratings)
Via Benzinga
BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up
Via Benzinga
3 Dow Jones Dividend Stocks With Above-Average Yields You Can Buy Now and Hold for at Least a Decade
Via The Motley Fool
Topics Stocks
3 Dow Jones Stocks to Keep an Eye On
Via StockStory
Topics Artificial Intelligence Stocks
Warren Buffett, Cathie Wood Share 2 Stock Investments In Common: Can You Guess What They Are?
Via Benzinga
Greenlight Capital Announces Q2 2025 Trades: New Positions in FLR and VSCO, Exit From VTRS
Via Benzinga
Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.
Via The Motley Fool
Topics Economy
Zevra Reported Its First-Ever Quarterly Profit. Why Shares Of The Top 6% Stock Crashed.
Via Investor's Business Daily
AMGN Q2 Deep Dive: Volume Growth, Pipeline Progress, and Guidance Raise Meet Investor Skepticism
Via StockStory
Topics Artificial Intelligence
Eli Lilly Shares Tumble After Disappointing Weight-Loss Pill Data
Via MarketMinute

Frequently Asked Questions

Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 272.03
When was Amgen last traded?
The last trade of Amgen was at 09/15/25 12:18 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 146.27B
How many shares of Amgen are outstanding?
Amgen has 146B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.